Advanced Stage III Ovarian Carcinoma: Prospective Randomized Trials Comparing Radiotherapy and Chemotherapy

References

• Barr W. (1980) Current problems in diagnosis and management. Ovarian Cancer: Proceedings of the International Symposium on Ovarian Cancer, Birmingham, September, 24—251979. Pergamon Press, Vol. 26: 3, In: Advances in the Biosciences
   Google Scholar
• Bush R S., Dembo A J. (1980) Current status of treatment for patients with ovarian cancer. Ovarian Cancer: Proceedings of the International Symposium on Ovarian Cancer, Birmingham, September, 24–251979. Pergamon Press, Vol. 26: 115, In: Advances in the Biosciences
   Google Scholar
• Decker D G., Malkasian G D., Taylor W F. Prognostic importance of histologic grading in ovarian carcinoma. National Cancer Institute Monograph 1975; 42: 9
   Google Scholar
• Edmonson J H., Fleming T R., Decker D G., Malkasian G D., Jorgensen E O., Jefferies J A., Webb M J., Kvols L K. Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease. Cancer Treat Rep 1979; 63: 241
   PubMedGoogle Scholar
• Fox H. (1980) Advances in the histopathology of ovarian tumours. Ovarian Cancer: Proceedings of the International Symposium on Ovarian Cancer, Birmingham, September, 24—251979. Pergamon Press, Vol. 26: 11, In: Advances in the Biosciences
   Google Scholar
• Frick G, Johnsson J E., Landberg T, Snorradottir M. Relaparotomy in advanced ovarian carcinoma. Acta Obstet Gynecol Scand 1978; 57: 165
   PubMed Web of Science ®Google Scholar
• Griffiths C T., Grogan R H., Hall T C. Advanced ovarian cancer. Primary treatment with surgery, radiotherapy and chemotherapy. Cancer 1972; 29: 1
   PubMedGoogle Scholar
• Griffiths C T., Parker L M., Fuller A F., Jr. Role of cyto-reductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep 1979; 63: 235
   PubMedGoogle Scholar
• Hanson M B., Powell D E., Donaldson E S., van Nagell J G., Jr. Treatment of epithelial ovarian carcinoma by surgical debulking followed by single alkylating agent chemotherapy. Gynecol Oncol 1980; 10: 337
   PubMedGoogle Scholar
• Hudson C N., Chir M. Surgical treatment of ovarian cancer. Gynecol Oncol 1973; l: 370
   Google Scholar
• Kalbfleisch I D., Prentice R L. The Statistical Analysis of Failure. Wiley & Sons, New York 1980; 70
   Google Scholar
• Kottmeir H L. Ovarian cancer with special regard to radiotherapy. Am J Roentgenol Rad Ther Nucl Med 1971; 111: 417
   Google Scholar
• Lee E, Desu M A. Computer program for comparing K samples with right-censored data. Computer Programs in Biomedicine 1972; 2: 315
   PubMedGoogle Scholar
• Long R TL, Johnson R E., Sala J M. Variations in survival among patients with carcinoma of the ovary. Analysis of 253 cases according to histologic type, anatomical stage and method of treatment. Cancer 1967; 20: 1195
   PubMedGoogle Scholar
• Malkasian G D., Decker D G., Webb M J. Histology of epithelial tumours of the ovary: Clinical usefulness and prognostic. Seminars in Oncology 1975; 2: 191
   Google Scholar
• Ozols R F., Garvin J A., Costa J, Simon M R., Young C R. Advanced Ovarian Cancer. Correlation of histologic grade with response to therapy and survival. Cancer 1980; 45: 572
   Google Scholar
• Schwartz P E., Smith J P. Second-look operations in ovarian cancer. Am J Obstet Gynecol 1980; 138: 1124
   PubMed Web of Science ®Google Scholar
• Sigurdsson K, Johnsson J E., Trope C. Carcinoma of the ovary in stage III. Effects of postoperative chemotherapy, radiation therapy and repeat laparotomy. Acta Radiol Oncol 1982; 21: 181
   PubMed Web of Science ®Google Scholar
• Sigurdsson K, Alm P, Gullberg B. Prognostic factors in malignant epithelial ovarian tumours. Gynecol Oncol 1983; 15: 370
   PubMedGoogle Scholar
• Smith J P. (1980) Surgery for ovarian cancer. Ovarian Cancer: Proceedings of the International Symposium on Ovarian Cancer, Birmingham, September, 24–251979. Pergamon Press, Vol 26: 137, In: Advances in the Biosciences
   Google Scholar
• Stanhope C R., Smith J P., Rutledge F. Second trial drugs in ovarian cancer. Gynecol Oncol 1977; 5: 52
   PubMed Web of Science ®Google Scholar
• The Swedish Cooperative Ovarian Cancer Study Group (SCOCSG). A prospective and randomized trial comparison of Melphalan versus Adriamycin-Melphalan in advanced ovarian carcinoma. Presented at the Annual Meeting of the American Society of Clinical Oncology, Washington, April 30-May 2, 1981. ASCO, Abstract C 533
   Google Scholar
• Young R C., Chabner B A., Hubbard S P., Fisher R I., Bender R A., Anderson R, Simon R M., Canellos G P., Devita V T. Advanced ovarian adenocarcinoma: A prospective clinical trial of Melphalan (L-PAM) versus combination chemotherapy. N Engl J Med 1978; 299: 1261
   PubMed Web of Science ®Google Scholar
• Young R C., Chassagne D, Dembo A J., Griffiths C T., Holland J F., Muggia F M., Salmon S E., Seski J, Smith J P., Wiltshaw E. Current and future management of ovarian cancer. Panel discussion. Therapeutic progress in ovarian cancer, testicular cancer and the sarcomas. Boerhaave Series. Vol. 16: 145
   Google Scholar